-

06:57:06 PM

Latest IGC Stock Market News

IGC - India Globalization Capital Inc

07/22/21 7:00 AM

NYSE : IGC

IGC Announces Issuance of Patent for the Treatment of Alzheimer’s Disease Using THC

India Globalization Capital, Inc. (the “Company”) (NYSE American: IGC) announced today that on July 20, 2021, the United States Patent and Trademark Office (“USPTO”) issued a patent (#11,065,225) for the treatment of Alzheimer’s disease entitled “Ultra-Low dose THC as a potential therapeutic and

RHEA-AI

neutral

06/23/21 6:50 PM

NYSE : IGC

clinical trial

IGC Completes the Final Cohort of Its Phase 1 Clinical Trial on Alzheimer’s Patients

India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) announces today it has completed Cohort 3 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from

RHEA-AI

neutral

06/14/21 6:00 PM

NYSE : IGC

earnings

IGC Reports Financial Results for the Fiscal Year Ended March 31, 2021

India Globalization Capital, Inc. (NYSE American: IGC) announces its financial results for the Fiscal Year Ended March 31, 2021.Revenue was approximately $898 thousand and $4.1 million for Fiscal 2021 and Fiscal 2020, respectively. In Fiscal 2021, the Company’s revenues were significantly

RHEA-AI

neutral

06/07/21 11:26 PM

NYSE : IGC

clinical trial

IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

India Globalization Capital, Inc. (“IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s

RHEA-AI

positive

03/08/21 6:33 PM

NYSE : IGC

IGC Receives Another Patent for a Cannabinoid-Based Cream for Treating Pain

India Globalization Capital, Inc. (the “Company”) (NYSE American: IGC) announced today that on March 2, 2021, the Company received one more patent (patent#10,933,082) from the United States Patent and Trademark Office (“USPTO”) for the Company’s cannabinoid composition and method for treating pain

RHEA-AI

neutral

02/22/21 8:00 AM

NYSE : IGC

clinical trial

Update On IGC’s Phase 1 Clinical Trial on Alzheimer’s Patients

India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) is pleased to announce the progress of its tetrahydrocannabinol (THC)-based phase 1 clinical trial, which was approved to proceed by the U.S. Food and Drug Administration (“FDA”) on July 30, 2020, as previously

RHEA-AI

neutral

02/12/21 7:00 PM

NYSE : IGC

earnings

IGC Reports Financial Results for December 31, 2020 Quarter

India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the quarter ended December 31, 2020, which is the third quarter of its 2021 fiscal year.Revenue in the quarter ended December 31, 2020 and December 31, 2019, was $108 thousand

RHEA-AI

negative

01/13/21 6:19 PM

NYSE : IGC

IGC Announces Results of its 2020 Annual Stockholders Meeting

India Globalization Capital, Inc. (NYSE AMERICAN: IGC) announces that during its Annual Meeting of Shareholders scheduled for, and convened on January 11, 2021, voting on all matters as disclosed on the Definitive Proxy on Form 14A filed with the SEC on December 8, 2020 were passed. Only

RHEA-AI

neutral

12/22/20 8:00 AM

NYSE : IGC

management

India Globalization Capital Nominates Mr. John E. Lynch to its Board of Directors

India Globalization Capital, Inc. (NYSE American: IGC), today announced that John E. Lynch has been nominated as a Class A independent director for election at the Company’s 2020 Annual Meeting of Stockholders, to be held on January 11, 2021, replacing Class A director Sudhakar Shenoy.Mr. Lynch

RHEA-AI

neutral